PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT
HONG KONG , Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting
SAN FRANCISCO and SUZHOU, China , Sept. 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction
Primary Endpoint Achieved in CBL-0202DD Phase 2 Trial— CBL-514 delivered statistically significant pain reduction across both FAS and PP populations compared with placebo. Expansion Opportunity Beyond ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
SINGAPORE , Sept. 23, 2026 /PRNewswire/ -- Mayo Clinic Laboratories  and Pathology Asia Holdings  (PAH) have announced a strategic investment and collaboration aimed at expanding access to ...
2026-09-23T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical Equipment 
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. Viva-Thera combines its first atomic-resolution MPER-TMD-CT ...
2026-09-23T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies
BEIJING , Sept. 22, 2026 /PRNewswire/ -- Tsingke today announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed ...
2026-09-22T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader ...
2026-09-22T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Angel Yeast Explores a New Approach to Salt Reduction Without Compromising Flavor
BEIJING , Sept. 22, 2026 /PRNewswire/ -- At the 2026 Food Science Salt Reduction Technology Symposium held recently in Beijing, Angel Yeast (SSE: 600298)  joined more than 200 experts and ...
2026-09-22T    Biotechnology   Food/Beverages   Health Care/Hospital   Trade show news 
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia ...
2026-09-22T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.